Neonatal administration of N-acetyl-L-aspartyl-L-glutamate induces early neurodegeneration in hippocampus and alters behaviour in young adult rats.
N-acetyl-L-aspartyl-L-glutamate (NAAG) is a dipeptide that could be considered a sequestered form of L-glutamate. As much as 25% of L-glutamate in brain may be present in the form of NAAG. NAAG is also one of the most abundant neuroactive small molecules in the CNS: it is an agonist at Group II metabotropic glutamate receptors (mGluR II) and, at higher concentrations, at the N-methyl-D-aspartate (NMDA) type of ionotropic glutamate receptors. As such, NAAG can be either neuroprotective or neurotoxic and, in fact, both characteristics have been discussed and described in the literature. In the present studies, 250 nmol NAAG was infused into each lateral cerebral ventricle of 12-day-old rat pups and, using Nissl-stained sections, neurodegeneration in the hippocampus was evaluated 24 or 96 h after the infusion. In several experiments, the neuronal death was also visualised by Fluoro-Jade B staining and studied by TUNEL technique. Some of the NAAG-treated animals were allowed to survive until 50 days post partum and subjected to behavioural (open field) tests. The administration of NAAG to 12-day-old rats resulted in extensive death of neurons particularly in the dentate gyrus of the hippocampus. The neurodegeneration was, in part, prevented by administration of an NMDA receptor antagonist MK-801 (0.1 mg/kg). The nuclear DNA-fragmentation demonstrated by TUNEL technique pointed to the presence of non-specific single-strand DNA cleavage. The NAAG-associated neonatal neuronal damage may have perturbed development of synaptic circuitry during adolescence as indicated by an altered performance of the experimental animals in the open field testing (changes in grooming activity) at postnatal day 50. The results underscore the potential neurotoxicity of NAAG in neonatal rat brain and implicate neonatally induced, NMDA receptor-mediated neuronal loss in the development of abnormal behaviour in young adult rats.
Bubeníková-Valesová
Vera
V
Prague Psychiatric Centre Affiliated with Third Faculty of Medicine & Centre of Neuropsychiatric Studies, 181 03 Prague 8, Czech Republic.
Balcar
Vladimir J
VJ
Tejkalová
Hana
H
Langmeier
Milos
M
St'astný
Frantisek
F
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D053938:DNA Fragmentation; D004151:Dipeptides / Q000008:administration & dosage / Q000502:physiology*; D005260:Female; D006624:Hippocampus / Q000187:drug effects / Q000254:growth & development / Q000473:pathology*; D020287:In Situ Nick-End Labeling; D007276:Injections, Intraventricular; D008297:Male; D019636:Neurodegenerative Diseases / Q000139:chemically induced / Q000473:pathology* / Q000503:physiopathology*; D009474:Neurons / Q000187:drug effects / Q000473:pathology*; D051381:Rats
D004151:Dipeptides; C027172:isospaglumic acid